Bioelnix Healthcare Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
as on 09-12-2024
- Paid Up Capital ₹ 0.10 M
as on 09-12-2024
- Company Age 4 Year, 5 Months
- Last Filing with ROC 31 Mar 2024
About Bioelnix Healthcare
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Sarthak Taluja, Shrey Jindal, and Vipul Dhingra serve as directors at the Company.
- CIN/LLPIN
U24232HR2020PTC087415
- Company No.
087415
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
12 Jul 2020
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Company Details
- Location
Yamuna Nagar, Haryana, India
- Telephone
- Email Address
- Website
-
- Social Media-
What products or services does Bioelnix Healthcare Private Limited offer?
Bioelnix Healthcare Private Limited offers a wide range of products and services, including Common Disease Medicines, Hair Growth Medicine, TB, Tumor & Cancer Drugs, Anti Cancer Medicines, Bird Food, Poultry & Animal Food, Animal Feed Supplement, Pharma & Bioanalytical Services, PCD Pharma Franchise, Pharmaceutical Syrup, Eye Drops.
Who are the key members and board of directors at Bioelnix Healthcare?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Vipul Dhingra  | Director | 12-Jul-2020 | Current |
| Sarthak Taluja | Director | 12-Jul-2020 | Current |
| Shrey Jindal | Director | 12-Jul-2020 | Current |
Financial Performance of Bioelnix Healthcare.
Enhance accessibility to Bioelnix Healthcare's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Bioelnix Healthcare?
Unlock access to Bioelnix Healthcare's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Bioelnix Healthcare?
Bioelnix Healthcare has a workforce of 0 employees as of Mar 28, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Bioelnix Healthcare, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Bioelnix Healthcare's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
